porcin
epidem
diarrhea
viru
pedv
highli
virul
contagi
piglet
caus
signific
damag
pork
industri
mani
countri
worldwid
commerci
drug
target
coronavirus
cov
studi
antipedv
inhibitor
coronaviru
proteas
pro
conserv
structur
catalyt
mechan
play
key
role
viral
polyprotein
process
thu
serv
appeal
antivir
drug
target
report
antipedv
effect
broadspectrum
inhibitor
target
pro
virus
picornaviruslik
superclust
highli
effect
pedv
pro
exert
similar
inhibitori
effect
two
pedv
strain
furthermor
structur
pedv
pro
complex
determin
elucid
structur
detail
analyz
differ
bind
pedv
pro
bind
transmiss
gastroenter
viru
tgev
pro
final
explor
substrat
specif
pedv
pro
site
analyz
effect
leu
group
modif
inhibit
pedv
infect
studi
help
us
understand
better
pedv
pro
substrat
specif
provid
inform
optim
develop
antivir
therapeut
coronavirus
porcin
epidem
diarrhea
viru
pedv
first
observ
europ
belong
genu
alphacoronaviru
famili
coronavirida
caus
sever
diarrhea
vomit
dehydr
high
mortal
neonat
piglet
result
sever
agricultur
loss
sinc
pedv
first
identifi
outbreak
report
mani
swineproduc
countri
notabl
europ
asia
sever
commerci
vaccin
wide
use
control
spread
pedv
asia
howev
sinc
frequent
outbreak
highli
virul
strain
pedv
occur
asia
outbreak
particularli
sever
china
vaccin
base
classic
strain
fail
control
infect
furthermor
vaccineresist
pedv
strain
emerg
unit
state
first
time
spread
rapidli
throughout
countri
caus
larg
econom
virus
loss
swine
industri
subsequ
north
america
europ
asia
also
attack
new
pedv
strain
although
newli
develop
vaccin
provid
effici
protect
vaccin
resist
may
still
appear
futur
due
genet
divers
epitop
among
differ
viru
genotyp
thu
necessari
develop
strategi
protect
pedv
infect
like
coronavirus
cov
pedv
rna
genom
encod
two
polyprotein
major
synthes
polyprotein
cleav
proteas
pro
main
proteas
conserv
site
essenti
viral
replic
thu
pro
appeal
target
design
anticoronaviru
therapi
notabl
pro
protein
differ
coronavirus
share
higher
sequenc
ident
conserv
catalyt
core
spike
protein
coronavirus
make
pro
ideal
broadspectrum
antivir
target
furthermor
two
highli
pathogen
human
coronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
came
anim
made
peopl
awar
import
crossspeci
transmiss
coronavirus
sinc
peopl
easi
access
swine
potenti
crossspeci
transmiss
pedv
ignor
therefor
necessari
develop
new
antipedv
therapi
coronaviru
pro
employ
conserv
cystein
histidin
residu
serv
princip
nucleophil
gener
acidbas
catalyst
respect
catalyt
site
pro
recogn
conserv
cleavag
site
contain
hydrophob
residu
prefer
l
posit
q
posit
small
aliphat
amino
acid
residu
g
posit
research
breakthrough
pro
structur
made
possibl
design
specif
inhibitor
coronaviru
replic
inhibitor
show
excel
broadspectrum
anticoronaviru
effect
dipeptidyl
bisulfit
adduct
salt
exert
excel
inhibitori
effect
picornavirus
coronavirus
enzymat
cellbas
assay
notabl
antivir
treatment
lead
full
recoveri
laboratori
cat
felin
infecti
periton
fip
highli
fatal
felin
diseas
caus
felin
coronaviru
fipv
commerci
vaccin
drug
addit
pedv
pro
share
sequenc
ident
fipv
pro
studi
detect
inhibitori
effect
pedv
pro
antivir
effect
inhibitor
studi
use
two
pedv
strain
name
final
determin
structur
pedv
pro
complex
compar
structur
avail
pro
structur
studi
provid
structur
model
develop
antipedv
drug
enrich
structur
knowledg
optim
broadspectrum
anticoronaviru
drug
figur
two
variant
target
target
synthes
labnetwork
global
ecommerc
platform
discoveri
compound
build
block
wwwlabnetworkcom
shanghai
china
puriti
higher
target
leu
replac
met
longer
side
chain
target
leu
replac
phe
side
chain
larger
volum
compound
dissolv
dimethyl
sulfoxid
dmso
concentr
mm
store
c
african
green
monkey
cell
vero
cell
cat
atcc
cultur
dulbecco
minimum
essenti
medium
hyclon
pittsburgh
pa
usa
supplement
fetal
bovin
serum
gibco
waltham
usa
virus
use
studi
attenu
strain
access
prototyp
strain
notabl
trypsin
ad
medium
cultur
viru
strategi
plasmid
construct
protein
express
purif
pedv
pro
describ
previou
studi
briefli
code
sequenc
fjzz
strain
ctermin
tag
insert
vector
protein
induc
mm
iptg
c
h
traptm
hp
column
ge
healthcar
pittsburgh
pa
usa
superdex
ge
healthcar
pittsburgh
pa
usa
column
use
protein
purif
fluoresc
peptid
substrat
genscript
piscataway
nj
usa
contain
ntermin
cleavag
site
pedv
pro
use
fret
assay
reaction
perform
solut
mm
hepe
mm
nacl
mm
edta
glycerol
mm
dtt
ph
total
volum
enzym
concentr
use
fret
assay
nm
substrat
concentr
concentr
rang
fluoresc
unit
upon
cleavag
monitor
everi
min
min
nm
excit
nm
rel
fluoresc
unit
rfu
determin
subtract
background
valu
substrat
control
well
without
proteas
fluoresc
valu
final
inhibitori
concentr
ic
calcul
use
graphpad
san
diego
ca
usa
assess
inhibit
ratio
differ
inhibitor
concentr
maxim
effect
ec
measur
cell
death
toxic
concentr
cc
vero
cell
determin
briefli
confluent
cell
grown
plate
treat
variou
concentr
h
well
includ
control
well
contain
dmso
cell
cytotox
measur
use
celltiterglo
luminesc
cell
viabil
assay
reagent
promega
madison
wi
usa
ec
measur
two
pedv
strain
use
cell
grown
confluenc
viru
ad
multipl
infect
moi
seri
concentr
well
includ
viru
cell
control
well
contain
dmso
cell
viabil
measur
h
h
respect
final
ec
calcul
use
graphpad
san
diego
ca
usa
assess
inhibit
ratio
differ
inhibitor
concentr
vero
cell
seed
plate
densiti
cell
per
well
cell
grown
confluenc
viru
inocul
cell
moi
concentr
use
ec
measur
incub
c
h
h
respect
cell
lyse
lysi
buffer
contain
proteas
inhibitor
beyotim
shanghai
china
ice
supernat
use
western
blot
assay
sdspage
protein
transfer
pvdf
membran
biorad
hercul
ca
usa
block
skim
milk
room
temperatur
h
membran
incub
antipedv
nucleocapsid
n
protein
monoclon
antibodi
antigapdh
monoclon
antibodi
proteintech
rosemont
il
usa
h
membran
incub
hrpconjug
secondari
antibodi
boster
biolog
technolog
pleasanton
ca
usa
min
membran
visual
use
enhanc
chemiluminesc
system
amersham
imag
ge
healthcar
pittsburgh
pa
usa
nucleocapsid
protein
level
normal
gapdh
protein
level
vero
cell
seed
plate
densiti
cell
per
well
inocul
well
moi
ad
seri
concentr
time
indirect
immunofluoresc
assay
perform
cell
die
briefli
cell
wash
pb
fixat
formaldehyd
pb
treat
triton
block
bsa
block
cell
incub
primari
antibodi
fitclabel
secondari
antibodi
thermofish
waltham
usa
dark
final
cell
examin
fluoresc
microscopi
stain
dapi
crystal
pedv
pro
gc
soak
obtain
describ
previou
studi
dissolv
elut
buffer
b
mm
tri
ph
mm
nacl
concentr
mm
ad
crystal
drop
equal
volum
crystal
soak
h
flashfrozen
singl
crystal
first
wash
ethylen
glycol
vv
cryoprotect
flashfrozen
liquid
nitrogen
data
collect
perform
beamlin
shanghai
synchrotron
radiat
facil
ssrf
use
mar
ccd
detector
mar
research
data
set
index
integr
scale
use
charlottesvil
va
usa
structur
solv
molecular
replac
phaser
phenix
berkeley
ca
usa
use
structur
pedv
pro
pdb
identifi
start
model
manual
model
build
perform
use
coot
oxon
uk
structur
refin
phenix
berkeley
ca
usa
refin
statist
shown
tabl
structur
figur
drawn
use
pymol
coordin
structur
factor
submit
pdb
access
number
highest
resolut
valu
written
parenthesi
r
merg
ii
ii
ii
intens
measur
reflect
h
averag
intens
multipl
observ
r
work
fo
fo
fo
fc
observ
calcul
structur
factor
respect
r
free
equival
r
work
measur
reflect
exclud
refin
set
asid
crossvalid
virus
compar
sequenc
pro
fjzz
strain
sequenc
pro
strain
strain
identifi
differ
one
six
residu
respect
differ
residu
far
substratebind
site
pedv
pro
pdb
fjzz
strain
might
caus
obviou
differ
enzymat
activ
thu
use
pedv
fjzz
pro
store
laboratori
inhibit
assay
result
indic
exert
strong
inhibitori
effect
pedv
pro
ic
approxim
figur
compar
ic
valu
coronavirus
report
previou
studi
virus
x
peer
review
highest
resolut
valu
written
parenthesi
rmerg
ii
ii
ii
intens
measur
reflect
h
averag
intens
multipl
observ
rwork
fo
fo
fo
fc
observ
calcul
structur
factor
respect
rfree
equival
rwork
measur
reflect
exclud
refin
set
asid
crossvalid
compar
sequenc
pro
fjzz
strain
sequenc
pro
strain
strain
identifi
differ
one
six
residu
respect
differ
residu
far
substratebind
site
pedv
pro
pdb
fjzz
strain
might
caus
obviou
differ
enzymat
activ
thu
use
pedv
fjzz
pro
store
laboratori
inhibit
assay
result
indic
exert
strong
inhibitori
effect
pedv
pro
approxim
figur
compar
valu
coronavirus
report
previou
studi
determin
inhibitori
effect
virus
vero
cell
test
cytotox
compound
cytotox
concentr
data
shown
seri
concentr
use
evalu
suppress
two
pedv
strain
ec
valu
similar
name
respect
figur
result
impli
effici
inhibit
replic
differ
pedv
strain
possibl
conserv
catalyt
core
pro
also
notabl
caus
cytopath
effect
cpe
much
faster
h
h
respect
howev
show
similar
inhibitori
effect
differ
treatment
time
two
virus
indic
quickli
enter
cell
block
viral
pro
strain
valu
similar
name
respect
figur
result
impli
effici
inhibit
replic
differ
pedv
strain
possibl
conserv
catalyt
core
pro
also
notabl
caus
cytopath
effect
cpe
much
faster
h
h
respect
howev
show
similar
inhibitori
effect
differ
treatment
time
two
virus
indic
quickli
enter
cell
block
viral
pro
western
blot
assay
introduc
quantifi
antivir
effect
two
virus
viral
nucleocapsid
protein
decreas
similar
dosedepend
manner
increas
concentr
figur
b
n
protein
show
signific
reduct
almost
undetect
result
indic
similar
inhibitori
effect
two
pedv
viru
strain
approxim
consist
cellbas
measur
assay
sinc
show
similar
effect
two
pedv
strain
perform
ifa
one
pedv
strain
compar
nondrugtr
cell
reduc
viru
infect
figur
almost
complet
inhibit
viru
replic
approxim
cell
syncytosi
disappear
abolish
infect
western
blot
assay
introduc
quantifi
antivir
effect
two
virus
viral
nucleocapsid
protein
decreas
similar
dosedepend
manner
increas
concentr
figur
b
n
protein
show
signific
reduct
almost
undetect
result
indic
similar
inhibitori
effect
two
pedv
viru
strain
ic
approxim
consist
cellbas
ic
measur
assay
sinc
show
similar
effect
two
pedv
strain
perform
ifa
one
pedv
strain
compar
nondrugtr
cell
reduc
viru
infect
figur
almost
complet
inhibit
viru
replic
approxim
cell
syncytosi
disappear
abolish
infect
elucid
inhibitori
mechan
provid
structur
model
inhibitor
optim
pedv
pro
determin
structur
pro
complex
investig
substratebind
site
reveal
promin
electron
densiti
two
monom
especi
subunit
figur
interfac
area
pedv
pro
buri
surfac
took
total
solventaccess
area
comput
use
pdbepisa
tool
http
pdbeorgpisa
aromat
ring
occupi
place
pedv
pro
substrat
residu
whose
side
chain
usual
point
solvent
contribut
littl
interfac
figur
glutamin
surrog
ring
leucin
fit
comfort
bind
site
respect
howev
subunit
b
densiti
aromat
ring
part
densiti
avail
glutamin
surrog
ring
data
shown
detail
interact
analyz
use
pymol
ligplot
program
figur
bisulfit
group
remov
compound
form
coval
bond
cy
hydrophob
interact
extens
proteas
compound
figur
four
residu
pedv
pro
cy
gln
glu
involv
hydrogen
bond
interact
figur
part
densiti
avail
glutamin
surrog
ring
data
shown
detail
interact
analyz
use
pymol
ligplot
program
figur
bisulfit
group
remov
compound
form
coval
bond
cy
hydrophob
interact
extens
proteas
compound
figur
four
residu
pedv
pro
cy
gln
glu
involv
hydrogen
bond
interact
figur
distanc
two
residu
label
shown
yellow
stick
glutamin
surrog
ring
leucin
fit
comfort
bind
site
respect
aromat
ring
point
solvent
c
diagram
detail
molecular
interact
proteas
residu
pocket
repres
green
line
shown
yellow
stick
hydrogen
bond
interact
shown
black
dash
line
structur
diagram
distribut
hydrophob
hydrophil
interact
interfac
pedv
pro
complex
residu
proteas
shown
orang
stick
red
arc
spoke
shown
blue
stick
carbon
nitrogen
oxygen
sulfur
atom
shown
black
blue
red
yellow
circl
respect
hydrogen
bond
shown
green
dash
line
label
distanc
donor
atom
correspond
acceptor
atom
hydrophob
interact
demonstr
arc
spoke
radiat
toward
atom
spoke
around
residu
shown
arc
spoke
contact
superposit
pedv
pro
complex
previous
report
apopedv
pro
structur
pdb
yield
root
mean
squar
deviat
rmsd
atom
chain
b
respect
find
indic
larg
conform
chang
overal
structur
occur
upon
ligand
bind
howev
examin
substratebind
pocket
chain
b
pedv
pro
complex
reveal
structur
differ
loop
compos
residu
assttstid
interestingli
electron
densiti
contour
residu
stt
chain
chain
b
result
suggest
part
loop
flexibl
orient
directli
influenc
entranc
size
substratebind
pocket
thr
loop
asn
locat
anoth
side
bind
pocket
protrud
pocket
form
narrow
entranc
width
figur
howev
size
entranc
may
chang
due
flexibl
loop
substrat
cleavag
superimposit
pedv
pedv
complex
pdb
indic
glutamin
surrog
ring
leucin
perfectli
occupi
posit
residu
peptid
substrat
respect
figur
conserv
residu
pedv
pro
recognit
sequenc
may
possibl
introduc
modif
site
may
difficult
examin
residu
cleavag
site
two
differ
residu
observ
val
met
determin
prefer
residu
pedv
pro
fluoresc
peptid
substrat
differ
residu
synthes
except
val
met
sever
residu
differ
side
chain
size
introduc
substrat
figur
fret
assay
use
differ
substrat
perform
describ
origin
substrat
without
mutat
exhibit
highest
cleavag
effici
show
littl
decreas
retain
activ
furthermor
larg
reduct
approxim
compar
observ
fw
thu
leu
prefer
residu
site
pedv
pro
explor
whether
replac
differ
residu
could
improv
inhibitori
effect
two
variant
synthes
target
leu
replac
met
longer
side
chain
target
leu
replac
phe
side
chain
larger
volum
ec
two
compound
fir
infect
measur
evalu
optim
effect
target
yield
ec
valu
respect
figur
show
higher
ec
valu
compar
leucin
consequ
leu
show
highest
inhibitori
effect
pedv
infect
report
show
excel
antivir
activ
transmiss
gastroenter
viru
tgev
structur
tgev
pro
complex
determin
compar
bind
pedv
pro
complex
pro
complex
residu
form
substratebind
pocket
conserv
two
pro
show
highli
similar
bind
mode
figur
rmsd
valu
list
residu
two
proteas
approxim
three
residu
loop
show
rmsd
valu
higher
figur
nonconserv
residu
pedv
pro
tgev
pro
form
similar
hydrogen
bond
interact
main
chain
oxygen
overal
two
rel
obviou
differ
loop
stabl
watermedi
contact
observ
thr
tgev
pro
complex
also
found
noroviru
nv
pro
picornaviru
pv
pro
complex
howev
loop
flexibl
hydrophob
interact
observ
pedv
pro
complex
b
asn
residu
side
chain
protrud
pocket
result
narrow
entranc
pedv
pro
tgev
pro
ala
residu
instead
figur
two
differ
caus
small
structur
deviat
leu
side
chain
aromat
ring
two
structur
respect
time
differ
influenc
size
entranc
pocket
might
affect
effici
entri
releas
pro
substrat
explor
whether
replac
differ
residu
could
improv
inhibitori
effect
two
variant
synthes
target
leu
replac
met
longer
side
chain
target
leu
replac
phe
side
chain
larger
volum
two
compound
fir
infect
measur
evalu
optim
effect
target
yield
valu
respect
figur
show
higher
valu
compar
leucin
consequ
leu
show
highest
inhibitori
effect
pedv
infect
complex
b
asn
residu
side
chain
protrud
pocket
result
narrow
entranc
pedv
pro
tgev
pro
ala
residu
instead
figur
two
differ
caus
small
structur
deviat
leu
side
chain
aromat
ring
two
structur
respect
time
differ
influenc
size
entranc
pocket
might
affect
effici
entri
releas
pro
substrat
figur
structur
align
pedv
pro
transmiss
gastroenter
viru
tgev
pro
structur
pedv
pro
red
superimpos
complex
structur
tgev
pro
blue
shown
stick
ball
residu
pro
involv
bind
label
shown
line
conserv
residu
two
pro
label
black
nonconserv
residu
label
differ
color
black
arrow
indic
structur
deviat
leu
side
chain
aromat
ring
two
structur
b
root
mean
squar
deviat
rmsd
valu
residu
involv
bind
two
structur
structur
pedv
pro
red
superimpos
complex
structur
tgev
pro
blue
shown
stick
ball
residu
pro
involv
bind
label
shown
line
conserv
residu
two
pro
label
black
nonconserv
residu
label
differ
color
black
arrow
indic
structur
deviat
leu
side
chain
aromat
ring
two
structur
b
root
mean
squar
deviat
rmsd
valu
residu
involv
bind
two
structur
viral
proteas
play
vital
role
viral
lifecycl
confirm
ideal
antivir
target
sever
remark
potent
drug
target
individu
viral
proteas
develop
import
human
pathogen
human
immunodefici
viru
hiv
hepat
c
viru
hcv
strategi
also
applic
coronavirus
encod
pro
respons
viral
polyprotein
cleavag
porcin
epidem
diarrhea
viru
pedv
coronaviru
one
major
threat
swine
industri
worldwid
develop
antivir
drug
target
pro
import
strategi
prevent
pedv
epidem
global
outbreak
sar
acceler
studi
anticoronaviru
inhibitor
develop
mani
research
commit
develop
broadspectrum
antivir
inhibitor
coronaviru
pro
studi
seri
avail
coronaviru
inhibitor
appli
fretbas
assay
identifi
effect
inhibitor
pedv
dipeptidyl
bisulfit
adduct
salt
work
best
select
subject
subsequ
experi
biochem
assay
yield
ic
pedv
pro
slightli
higher
transmiss
gastroenter
viru
tgev
pro
lower
sarscov
pro
subsequ
detect
antipedv
effect
cell
two
pedv
strain
select
evalu
antivir
effect
sequenc
align
pro
strain
reveal
seven
differ
residu
howev
ec
western
blot
assay
show
similar
antivir
effect
two
viru
strain
figur
seven
residu
differ
strain
involv
bind
pocket
thu
obviou
influenc
antivir
effect
exhibit
potent
antivir
activ
high
nanomolar
ec
valu
tgev
fipv
howev
obtain
low
micromolar
ec
valu
pedv
strain
analyz
bind
detail
pedv
pro
complex
anoth
avail
pro
structur
anoth
coronaviru
tgev
howev
residu
involv
bind
conserv
loop
entranc
size
show
differ
figur
howev
consid
activ
protein
biochem
level
differ
cellular
level
structur
differ
may
reason
differ
antivir
activ
pedv
tgev
fipv
observ
cellular
assay
antivir
effect
complic
cellular
level
may
affect
express
level
pro
viral
replic
characterist
pharmacokinet
differ
host
cell
determin
residu
specif
pedv
pro
optim
leu
show
best
effect
assay
figur
fret
assay
use
peptid
substrat
differ
residu
longer
side
chain
shorter
side
chain
show
lower
cleavag
effici
figur
suggest
length
leu
fit
best
subsit
larger
pyrrolidin
benzyl
side
chain
group
result
great
increas
activ
indic
residu
side
chain
volum
larger
leu
accept
subsit
prove
even
larger
side
chain
almost
uncleav
figur
two
modifi
compound
target
target
show
lower
inhibitori
effect
compar
lm
stronger
effect
lp
figur
consist
result
fretbas
specif
assay
conclus
leu
prefer
group
subsit
could
ration
design
base
leu
futur
perhap
replac
one
hydrogen
leu
side
chain
atom
caus
minor
chang
might
produc
stronger
bind
thu
result
better
inhibit
aromat
ring
stretch
solvent
may
serv
primari
modif
site
anim
experi
requir
evalu
therapeut
effect
porcin
epidem
diarrhea
ped
piglet
gener
exert
excel
inhibitori
effect
differ
pedv
strain
target
pro
great
potenti
could
modifi
produc
strong
therapeut
effect
anim
studi
provid
inform
optim
inhibitor
author
contribut
design
experi
gp
zff
gy
xw
perform
experi
gy
xw
xt
ys
prepar
manuscript
gp
gy
xw
proof
manuscript
gy
xw
zff
gp
author
read
agre
publish
version
manuscript
